Protected From a Form of Cell Death, Women are More Resilient to Kidney Disease
A study led by Duke Health researchers provides some insights: Females, it turns out, have an advantage at the molecular level that protects them from a form of cell death that occurs in injured kidneys. This protection could be exploited as a potential therapeutic.
Duke Experts Participate in First Use of Fetal Therapy for Pompe Disease
Experts at Duke Health were among a multi-national team involved in treating a fetus for infantile-onset Pompe disease using an enzyme replacement therapy – a first in the world.
The Kids Are Not Alright: NC-PAL expands access to pediatric mental health services
NC-PAL is a free provider-to-provider consultation line and education program available to all clinicians across the state for questions about behavioral health or psychiatric medication management for their pediatric and perinatal patients. Nicole Heilbron and Gary Maslow are leads of the program, part of the statewide effort to address the youth mental health crisis.
Closing the Gap in Veteran Suicide Research
Operation Deep Dive is a partnership between Duke School of Medicine and American Warrior Project to examine the factors and causes of suicide among veterans and former service members.
Modeling a Pandemic in a Tube
New tool provides a framework to identify human genetic determinants of infectious disease outcomes.
Chest Pain Patients Benefit from Precision Diagnostic Testing Approach
A study comparing two approaches for diagnosing heart disease found that a risk analysis strategy is superior to the usual approach of immediately performing functional tests or catheterization for low- to intermediate-risk patients with new-onset chest pain.
Two Alzheimer’s Drugs Tested Head-to-Head in First-Ever Virtual Clinical Trial
An estimated 6.2 million Americans ages 65 and older are living with Alzheimer's disease.
Mechanism Identified for Drug Resistance in Glioblastoma Brain Tumors
Duke Health researchers have identified a unique process within the environment of deadly brain tumors that drives resistance to immune-boosting therapies and could be targeted to promote the effects of those drugs.
Doug and Stefanie Kahn: New Gift Supports Work to Uncover the Genesis of Alzheimer’s Disease
Doug and Stefanie Kahn are very familiar with the statistics.
The Centers for Disease Control and Prevention estimates as many as 5.8 million Americans had Alzheimer’s disease in 2020, and this number is expected to nearly triple in the next 30 years. Worldwide as many as 50 million people have Alzheimer’s.
Modeling Compassion: Diabetes Outpatient Clinic Teaches More Than Medicine
The Schwartz Center for Compassionate Healthcare this year selected the Diabetes Clinic at Duke Outpatient Clinic (DOC-DM) — a community-based practice that treats underserved and often the most medically-complex patients in the Duke system regardless of payer status - as one of eight semi-finalists in the county for its National Compassionate Caregivers of the Year Award.